Literature surrounding the ethics of neurotechnology surfaces important questions about the potential for the technology to serve only narrow populations due to flaws in hardware design, coded bias, and restrictive access to technologies. By addressing challenges in early-stage research and development upstream, teams can reduce the risk of exclusive design/features being incorporated into a product further downstream. This article suggests that strategies in hiring, experimental design, research participant recruitment and retention, and ethics engagement in early-stage research represent meaningful ways for companies to build inclusive technologies and maximize value for their end users.
No takes yet. Share an insight, caveat, or question.
Lenora Armstrong (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: